Pancreatic Cancer Research

ResearcherWest China Medical Center of Sichuan UniversityActive in the last 2 years

Congya Zhou

Matched on OpenAlex author ID A5110840165. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma pa… Co-author DOI 10.1097/md.0000000000037322↗
  2. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer. Co-author DOI 10.1002/cam4.5774↗
  3. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma. First author DOI 10.1097/md.0000000000019413↗
  4. Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis. Co-author DOI 10.3892/ol.2019.10889↗
  5. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.1833↗
  6. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.4529↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qing Zhu · 5 shared papers, 2015–2023 · strength 0.50
  2. Zhengchao Gao · 1 shared paper, 2024 · strength 0.31
  3. Ningna Weng · 2 shared papers, 2019–2020 · strength 0.20
  4. Qunli Xiong · 1 shared paper, 2023 · strength 0.18
  5. Yang Yang · 1 shared paper, 2023 · strength 0.18
  6. Yongfeng Xu · 1 shared paper, 2023 · strength 0.18
  7. Zhu Zeng · 1 shared paper, 2023 · strength 0.18
  8. Suxia Han · 2 shared papers, 2015–2019 · strength 0.14
  9. Shuangshuang Li · 1 shared paper, 2020 · strength 0.11
  10. Xin Sui · 1 shared paper, 2018 · strength 0.08
  11. Su‐xia Han · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.